ORKA

Oruka Therapeutics, Inc. Common Stock
ORKA

Overview Fund Activity

22 hedge funds and large institutions have $6.09M invested in Oruka Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
-3
Holders Change %
-12%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
3
Closed
6
Calls
$165K
Puts
$131K
Net Calls
+$34K
Net Calls Change
+$2.96M

Top Buyers

1
M
1
Murchinson
Ontario, Canada
$120K
2
NM
2
Newtyn Management
New York
$1.27M
3
Jane Street
3
Jane Street
New York
$34.6K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$83K
5
TRCT
5
Tower Research Capital (TRC)
New York
$3K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
Group One Trading
2
Group One Trading
Illinois
$0
3
SM
3
SG3 Management
Puerto Rico
$0
4
Millennium Management
4
Millennium Management
New York
$0
5
Citadel Advisors
5
Citadel Advisors
Florida
$12.9K
Name Holding Trade Value Shares
Change 		Shares
Change %
VF
26
Virtu Financial
New York
– -$29K -1,185 Closed
Simplex Trading
27
Simplex Trading
Illinois
– -$1K -43 Closed
1
2